Saturday, February 14

Rocket Lab Announces Third Quarter 2025 Financial Results, Posts Record Quarterly Revenue of $155m, Representing 48% Year-on-Year Growth at Record Gross Margin


Rocket Lab Corporation
Rocket Lab Corporation

LONG BEACH, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab”, “the Company”, “we,” “us,” or “our”), a global leader in launch services and space systems, today shared the financial results for fiscal third quarter ended September 30, 2025.

Rocket Lab founder and CEO, Sir Peter Beck, said: “This past quarter we’ve once again delivered record revenue of $155m at record GAAP gross margin of 37%, and a new annual launch record is just days away. With progress across our major space systems programs, record backlog of contracts for our launch services business, and well-timed, strategic M&A in growth areas that are well-aligned with next-generation defense programs like Golden Dome and the Space Development Agency’s future constellations, our momentum is strong and we’re poised to deliver long-term exciting growth.”

Business Highlights for the Third Quarter 2025, plus updates since September 30, 2025.

  • Secured 17x Electron launch contracts in Q3, 2025 – a record-breaking quarter of dedicated launch contracts for our industry-leading small launch vehicle. Rocket Lab is also set to surpass its previous annual launch record in the fourth quarter, and remains on track to close out the year with 20+ launches.

  • Successfully launched two back-to-back HASTE missions across the quarter at an unprecedented pace of delivery for the nation that supports critical advancements in hypersonic technology.

  • Closed our acquisition of electro-optical and infrared sensor maker Geost for up to $325 million in a cash-plus-equity transaction, expanding our end-to-end capabilities for U.S. national security with launch, spacecraft, and now payloads. Other significant M&A activity for the quarter included the completed financial restructure of German laser communications company Mynaric as part of our intended acquisition process. Rocket Lab also exited the quarter with $1+ billion in liquidity following the Company’s recent at-the-market offering program, further strengthening our capital position to act decisively on our robust M&A pipeline.

  • Officially opened Launch Complex 3, the test and launch site for the Company’s new medium-lift reusable rocket Neutron.

  • Updating our Neutron schedule that has the rocket arriving at Rocket Lab Launch Complex 3 in Q1, 2026, with the first launch thereafter, pending the successful completion of the vehicle’s qualification testing and acceptance program.

Fourth Quarter 2025 Guidance
For the fourth quarter of 2025, Rocket Lab expects:

  • Revenue between $170 million and $180 million.

  • GAAP Gross Margins between 37% and 39%.

  • Non-GAAP Gross Margins between 43% and 45%.

  • GAAP Operating Expenses between $122 million and $128 million.

  • Non-GAAP Operating Expenses between $107 million and $113 million.

  • Expected Interest Income, net $3.5 million.

  • Adjusted EBITDA loss of $23 million and $29 million.

  • Basic Weighted Average Common Shares Outstanding of 571 million, including approximately 46 million of Series A Convertible Participating Preferred Shares.

See “Use of Non-GAAP Financial Measures” below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q4 2025 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $15 million to $17 million in Q4 2025.

Conference Call Information
Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our third quarter, to provide our outlook for the fourth quarter, and other updates.

The live webcast and a replay of the webcast will be available on Rocket Lab’s Investor Relations website: https://investors.rocketlabcorp.com/

Rocket Lab Investor Relations Contact
Patrick Vorenkamp
investors@rocketlabusa.com

Rocket Lab Media Contact
Murielle Baker
media@rocketlabusa.com

About Rocket Lab
Rocket Lab is a leading space company that provides launch services, spacecraft, payloads and satellite components serving commercial, government, and national security markets. Rocket Lab’s Electron rocket is the world’s most frequently launched orbital small rocket; its HASTE rocket provides hypersonic test launch capability for the U.S. government and allied nations; and its Neutron launch vehicle in development will unlock medium launch for constellation deployment, national security and exploration missions. Rocket Lab’s spacecraft and satellite components have enabled more than 1,700 missions spanning commercial, defense and national security missions including GPS, constellations, and exploration missions to the Moon, Mars, and Venus. Rocket Lab is a publicly listed company on the Nasdaq stock exchange (RKLB). Learn more at www.rocketlabcorp.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expectations of financial results for the first quarter of 2025, launch and space systems operations, launch schedule and window, safe and repeatable access to space, Neutron development and anticipated timeline to launch, operational expansion and business strategy are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “strategy,” “future,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to the factors, risks and uncertainties included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.investors.rocketlabcorp.com, which could cause our actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

Use of Non-GAAP Financial Measures
We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America (“GAAP”) with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company’s ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:

Adjusted EBITDA
EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.

Other Non-GAAP Financial Measures
Non-GAAP gross profit, gross margin, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.

 

 

 

 

ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024
(unaudited; in thousands, except share and per share data)

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2025

 

2024

 

2025

 

2024

Revenues:

 

 

 

 

 

 

 

Product revenues

$

104,042

 

 

$

79,419

 

 

$

277,571

 

 

$

205,848

 

Service revenues

 

51,038

 

 

 

25,389

 

 

 

144,576

 

 

 

97,978

 

Total revenues

 

155,080

 

 

 

104,808

 

 

 

422,147

 

 

 

303,826

 

Cost of revenues:

 

 

 

 

 

 

 

Cost of product revenues

 

72,841

 

 

 

58,448

 

 

 

188,402

 

 

 

153,215

 

Cost of service revenues

 

24,925

 

 

 

18,364

 

 

 

94,796

 

 

 

71,279

 

Total cost of revenues

 

97,766

 

 

 

76,812

 

 

 

283,198

 

 

 

224,494

 

Gross profit

 

57,314

 

 

 

27,996

 

 

 

138,949

 

 

 

79,332

 

Operating expenses:

 

 

 

 

 

 

 

Research and development, net

 

70,694

 

 

 

47,723

 

 

 

191,937

 

 

 

126,139

 

Selling, general and administrative

 

45,589

 

 

 

32,172

 

 

 

124,808

 

 

 

91,445

 

Total operating expenses

 

116,283

 

 

 

79,895

 

 

 

316,745

 

 

 

217,584

 

Operating loss

 

(58,969

)

 

 

(51,899

)

 

 

(177,796

)

 

 

(138,252

)

Other income (expense):

 

 

 

 

 

 

 

Interest expense, net

 

(590

)

 

 

(454

)

 

 

(5,547

)

 

 

(2,176

)

Gain (loss) on foreign exchange

 

388

 

 

 

(490

)

 

 

(235

)

 

 

(465

)

Other (expense) income, net

 

(177

)

 

 

1,848

 

 

 

(675

)

 

 

3,152

 

Total other (expense) income, net

 

(379

)

 

 

904

 

 

 

(6,457

)

 

 

511

 

Loss before income taxes

 

(59,348

)

 

 

(50,995

)

 

 

(184,253

)

 

 

(137,741

)

Benefit (provision) for income taxes

 

41,091

 

 

 

(944

)

 

 

38,966

 

 

 

(89

)

Net loss

$

(18,257

)

 

$

(51,939

)

 

$

(145,287

)

 

$

(137,830

)

Net loss per share attributable to Rocket Lab Corporation:

 

 

 

 

 

 

 

Basic and diluted

$

(0.03

)

 

$

(0.10

)

 

$

(0.28

)

 

$

(0.28

)

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

Basic and diluted

 

528,725,980

 

 

 

497,701,715

 

 

 

516,560,266

 

 

 

493,976,025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 2025 AND DECEMBER 31, 2024
(unaudited; in thousands, except share and per share values)

 

 

 

 

 

September 30, 2025
(unaudited)

 

December 31, 2024

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

807,875

 

 

$

271,042

 

Marketable securities, current

 

168,865

 

 

 

147,948

 

Accounts receivable, net

 

59,086

 

 

 

36,440

 

Contract assets

 

52,785

 

 

 

63,108

 

Inventories

 

144,999

 

 

 

119,074

 

Prepaids and other current assets

 

82,813

 

 

 

55,009

 

Total current assets

 

1,316,423

 

 

 

692,621

 

Non-current assets:

 

 

 

Property, plant and equipment, net

 

278,003

 

 

 

194,838

 

Intangible assets, net

 

231,984

 

 

 

58,637

 

Goodwill

 

217,709

 

 

 

71,020

 

Right-of-use assets – operating leases

 

90,844

 

 

 

53,664

 

Right-of-use assets – finance leases

 

14,022

 

 

 

14,396

 

Marketable securities, non-current

 

46,202

 

 

 

60,686

 

Restricted cash

 

4,835

 

 

 

4,260

 

Deferred income tax assets, net

 

 

 

 

3,010

 

Other non-current assets

 

21,373

 

 

 

31,210

 

Total assets

$

2,221,395

 

 

$

1,184,342

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Trade payables

$

61,229

 

 

$

53,059

 

Accrued expenses

 

17,961

 

 

 

19,460

 

Employee benefits payable

 

82,174

 

 

 

20,847

 

Contract liabilities

 

208,243

 

 

 

216,160

 

Current installments of long-term borrowings

 

17,090

 

 

 

12,045

 

Other current liabilities

 

27,760

 

 

 

17,954

 

Total current liabilities

 

414,457

 

 

 

339,525

 

Non-current liabilities:

 

 

 

Convertible senior notes, net

 

347,014

 

 

 

345,392

 

Long-term borrowings, net, excluding current installments

 

51,267

 

 

 

44,049

 

Non-current operating lease liabilities

 

86,505

 

 

 

51,965

 

Non-current finance lease liabilities

 

14,742

 

 

 

14,970

 

Deferred tax liabilities

 

3,007

 

 

 

891

 

Other non-current liabilities

 

23,417

 

 

 

5,097

 

Total liabilities

 

940,409

 

 

 

801,889

 

COMMITMENTS AND CONTINGENCIES

 

 

 

Stockholders’ equity:

 

 

 

Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 45,951,250 and 0 at September 30, 2025 and December 31, 2024, respectively

 

5

 

 

 

 

Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 542,175,866 and 504,453,785 at September 30, 2025 and December 31, 2024, respectively; outstanding shares: 496,224,616 and 504,453,785 at September 30, 2025 and December 31, 2024, respectively

 

50

 

 

 

50

 

Treasury stock, at cost; shares: 45,951,250 and 0 at September 30, 2025 and December 31, 2024, respectively

 

 

 

 

 

Additional paid-in capital

 

2,241,982

 

 

 

1,198,909

 

Accumulated deficit

 

(958,988

)

 

 

(813,701

)

Accumulated other comprehensive loss

 

(2,063

)

 

 

(2,805

)

Total stockholders’ equity

 

1,280,986

 

 

 

382,453

 

Total liabilities and stockholders’ equity

$

2,221,395

 

 

$

1,184,342

 

 

 

 

 

 

 

 

 

ROCKET LAB CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024
(unaudited; in thousands)

 

 

 

For the Nine Months Ended September 30,

 

2025

 

2024

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

Net loss

$

(145,287

)

 

$

(137,830

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

29,191

 

 

 

24,516

 

Stock-based compensation expense

 

52,894

 

 

 

39,944

 

Loss (gain) on disposal of assets

 

2,356

 

 

 

(2,356

)

Loss on extinguishment of long-term debt

 

 

 

 

1,330

 

Amortization of debt issuance costs and discount

 

2,551

 

 

 

2,272

 

Noncash lease expense

 

5,975

 

 

 

4,437

 

Change in the fair value of contingent consideration

 

 

 

 

(218

)

Accretion of marketable securities purchased at a discount

 

(1,599

)

 

 

(2,272

)

Deferred income taxes

 

(33,049

)

 

 

2,310

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable, net

 

(19,442

)

 

 

12,928

 

Contract assets

 

12,608

 

 

 

(36,510

)

Inventories

 

(25,567

)

 

 

(7,118

)

Prepaids and other current assets

 

(17,455

)

 

 

1,951

 

Other non-current assets

 

10,132

 

 

 

544

 

Trade payables

 

(1,634

)

 

 

13,853

 

Accrued expenses

 

2,671

 

 

 

2,980

 

Employee benefits payables

 

43,417

 

 

 

3,525

 

Contract liabilities

 

(9,187

)

 

 

27,791

 

Other current liabilities

 

(1,358

)

 

 

4,088

 

Non-current lease liabilities

 

(8,269

)

 

 

(4,321

)

Other non-current liabilities

 

62

 

 

 

1,653

 

Net cash used in operating activities

 

(100,990

)

 

 

(46,503

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

Purchases of property, equipment and software

 

(106,631

)

 

 

(45,539

)

Proceeds on disposal of assets, net

 

397

 

 

 

11,756

 

Cash paid for business combination, net of acquired cash

 

(132,441

)

 

 

 

Purchases of marketable securities

 

(187,780

)

 

 

(149,548

)

Maturities of marketable securities

 

179,822

 

 

 

102,930

 

Sale of marketable securities

 

3,383

 

 

 

 

Net cash used in investing activities

 

(243,250

)

 

 

(80,401

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

Proceeds from ATM Equity Offerings

 

865,453

 

 

 

 

Issuance costs related to ATM Equity Offerings

 

(20,134

)

 

 

 

Proceeds from the exercise of stock options

 

2,539

 

 

 

2,074

 

Proceeds from Employee Stock Purchase Plan

 

7,751

 

 

 

4,098

 

Proceeds from sale of employees restricted stock units to cover taxes

 

80,659

 

 

 

14,991

 

Minimum tax withholding paid on behalf of employees for restricted stock units

 

(65,672

)

 

 

(15,169

)

Purchase of capped calls related to issuance of convertible senior notes

 

 

 

 

(43,168

)

Proceeds from issuance of convertible senior notes

 

 

 

 

355,000

 

Proceeds from secured term loans

 

26,716

 

 

 

 

Repayments on secured term loan

 

(15,103

)

 

 

(48,853

)

Payment of debt issuance costs

 

(278

)

 

 

(12,205

)

Finance lease principal payments

 

(197

)

 

 

(269

)

Net cash provided by financing activities

 

881,734

 

 

 

256,499

 

Effect of exchange rate changes on cash and cash equivalents

 

(86

)

 

 

763

 

Net increase in cash and cash equivalents and restricted cash

 

537,408

 

 

 

130,358

 

Cash and cash equivalents, and restricted cash, beginning of period

 

275,302

 

 

 

166,434

 

Cash and cash equivalents, and restricted cash, end of period

$

812,710

 

 

$

296,792

 

 

 

 

 

 

 

 

 

ROCKET LAB CORPORATION AND SUBSIDIARIES
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024
(unaudited; in thousands)

The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2025

 

2024

 

2025

 

2024

NET LOSS

$

(18,257

)

 

$

(51,939

)

 

$

(145,287

)

 

$

(137,830

)

Depreciation

 

6,490

 

 

 

4,793

 

 

 

18,061

 

 

 

14,513

 

Amortization

 

5,236

 

 

 

3,302

 

 

 

11,130

 

 

 

10,003

 

Stock-based compensation expense

 

15,727

 

 

 

12,896

 

 

 

52,894

 

 

 

39,944

 

Transaction costs

 

5,118

 

 

 

23

 

 

 

11,504

 

 

 

407

 

Interest expense, net

 

590

 

 

 

454

 

 

 

5,547

 

 

 

2,176

 

Change in fair value of contingent consideration

 

 

 

 

 

 

 

 

 

 

(218

)

(Benefit) provision for income taxes

 

(41,091

)

 

 

944

 

 

 

(38,966

)

 

 

89

 

(Gain) loss on foreign exchange

 

(388

)

 

 

490

 

 

 

235

 

 

 

465

 

Accretion of marketable securities and cash equivalents purchased at a discount

 

(553

)

 

 

(666

)

 

 

(1,810

)

 

 

(2,272

)

Loss (gain) on disposal of assets

 

853

 

 

 

(1,164

)

 

 

2,356

 

 

 

(2,356

)

Employee retention credit

 

 

 

 

 

 

 

515

 

 

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

1,330

 

ADJUSTED EBITDA

$

(26,275

)

 

$

(30,867

)

 

$

(83,821

)

 

$

(73,749

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

2025

 

2024

 

2025

 

2024

GAAP Gross profit

$

57,314

 

 

$

27,996

 

 

$

138,949

 

 

$

79,332

 

Stock-based compensation

 

3,539

 

 

 

3,029

 

 

 

12,351

 

 

 

10,205

 

Amortization of purchased intangibles and favorable lease

 

4,126

 

 

 

1,763

 

 

 

7,772

 

 

 

5,247

 

Employee retention credit

 

 

 

 

 

 

 

278

 

 

 

 

Non-GAAP Gross profit

$

64,979

 

 

$

32,788

 

 

$

159,350

 

 

$

94,784

 

Non-GAAP Gross margin

 

41.9

%

 

 

31.3

%

 

 

37.7

%

 

 

31.2

%

 

 

 

 

 

 

 

 

GAAP Research and development, net

$

70,694

 

 

$

47,723

 

 

$

191,937

 

 

$

126,139

 

Stock-based compensation

 

(5,588

)

 

 

(4,626

)

 

 

(16,055

)

 

 

(13,660

)

Amortization of purchased intangibles and favorable lease

 

 

 

 

(302

)

 

 

(329

)

 

 

(686

)

Employee retention credit

 

 

 

 

 

 

 

(88

)

 

 

 

Non-GAAP Research and development, net

$

65,106

 

 

$

42,795

 

 

$

175,465

 

 

$

111,793

 

 

 

 

 

 

 

 

 

GAAP Selling, general and administrative

$

45,589

 

 

$

32,172

 

 

$

124,808

 

 

$

91,445

 

Stock-based compensation

 

(6,600

)

 

 

(5,241

)

 

 

(24,488

)

 

 

(16,079

)

Amortization of purchased intangibles and favorable lease

 

(846

)

 

 

(960

)

 

 

(2,250

)

 

 

(3,274

)

Transaction costs

 

(5,118

)

 

 

(23

)

 

 

(11,504

)

 

 

(407

)

Change in fair value of contingent consideration

 

 

 

 

 

 

 

 

 

 

218

 

Employee retention credit

 

 

 

 

 

 

 

(149

)

 

 

 

Non-GAAP Selling, general and administrative

$

33,025

 

 

$

25,948

 

 

$

86,417

 

 

$

71,903

 

 

 

 

 

 

 

 

 

GAAP Operating expenses

$

116,283

 

 

$

79,895

 

 

$

316,745

 

 

$

217,584

 

Stock-based compensation

 

(12,188

)

 

 

(9,867

)

 

 

(40,543

)

 

 

(29,739

)

Amortization of purchased intangibles and favorable lease

 

(846

)

 

 

(1,262

)

 

 

(2,579

)

 

 

(3,960

)

Transaction costs

 

(5,118

)

 

 

(23

)

 

 

(11,504

)

 

 

(407

)

Change in fair value of contingent consideration

 

 

 

 

 

 

 

 

 

 

218

 

Employee retention credit

 

 

 

 

 

 

 

(237

)

 

 

 

Non-GAAP Operating expenses

$

98,131

 

 

$

68,743

 

 

$

261,882

 

 

$

183,696

 

 

 

 

 

 

 

 

 

GAAP Operating loss

$

(58,969

)

 

$

(51,899

)

 

$

(177,796

)

 

$

(138,252

)

Total non-GAAP adjustments

 

25,817

 

 

 

15,944

 

 

 

75,264

 

 

 

49,340

 

Non-GAAP Operating loss

$

(33,152

)

 

$

(35,955

)

 

$

(102,532

)

 

$

(88,912

)

 

 

 

 

 

 

 

 

GAAP Total other (expense) income, net

$

(379

)

 

$

904

 

 

$

(6,457

)

 

$

511

 

(Gain) loss on foreign exchange

 

(388

)

 

 

490

 

 

 

235

 

 

 

465

 

Loss (gain) on disposal of assets

 

853

 

 

 

(1,164

)

 

 

2,356

 

 

 

(2,356

)

Loss on extinguishment of debt

 

 

 

 

 

 

 

 

 

 

1,330

 

Non-GAAP Total other income (expense), net

$

86

 

 

$

230

 

 

$

(3,866

)

 

$

(50

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *